Cannabidiol-2’,6’-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoeshl mice

Journal of Toxicological Sciences

Volumn 40, Issue 6, 2015, Pages 739-743

  Takeda, Shuso ^a,b   Hirota, Rena ^a   Teradaira, Sari ^a   Takeda Imoto, Masumi ^a   Watanabe, Kazuhito ^c   Toda, Akihisa ^a   Aramaki, Hironori ^a  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

Author keywords

6 dimethyl ether; Apolipoprotein E; Cannabidiol; Cannabidiol 2 ; Fiber type cannabis plant

Indexed keywords

APOLIPOPROTEIN E; CANNABIDIOL DIMETHYL ETHER; CYTOCHROME B5; CYTOCHROME P450; OXIDIZED LOW DENSITY LIPOPROTEIN; CANNABIDIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHOLESTEROL TRANSPORT; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; LETTER; LIPOPROTEIN DEFICIENCY; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; WEIGHT GAIN; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; DEFICIENCY; DRUG EFFECTS; STIMULATION; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; APOLIPOPROTEINS E; CANNABIDIOL; MALE; MICE, INBRED BALB C; MICE, TRANSGENIC; STIMULATION, CHEMICAL; WEIGHT GAIN;

EID: 84946821438     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.40.739     Document Type: Letter

References (21)

1. Bornheim, L.M. and Correia, M.A. (1989): Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Mol. Pharmacol., 36, 377-383.
2. Gohda, H., Narimatsu, S., Yamamoto, I. and Yoshimura, H. (1990): In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: on the formation mechanism of cannabielsoin-type metabolite from cannabidiol. Chem. Pharm. Bull., 38, 1697-1701.
3. Ignatowska-Jankowska, B., Jankowski, M.M. and Swiergiel, A.H. (2011): Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci. Lett., 490, 82-84.
4. Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V. and Mechoulam, R. (2009): Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci., 30, 515-527 [Erratum in Trends Pharmacol. Sci., 30, 609 (2009)].
5. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
6. Mahley, R.W., Huang, Y. and Weisgraber, K.H. (2006): Putting cholesterol in its place: apoE and reverse cholesterol transport. J. Clin. Invest., 116, 1226-1229.
7. Matsushima, Y., Sakurai, T., Ohoka, A., Ohnuki, T., Tada, N., Asoh, Y. and Tachibana, M. (2001): Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J. Atheroscler. Thromb., 8, 71-79.
8. Nishibayashi, H. and Sato, R. (1968): Preparation of hepatic microsomal particles containing P-450 as the sole heme constituent and absolute spectra of P-450. J. Biochem., 63, 766-779.
9. Omura, T. and Sato, R. (1964): The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
10. Schreyer, S.A., Vick, C., Lystig, T.C., Mystkowski, P. and LeBoeuf, R.C. (2002): LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Meta., 282, E207-E214.
11. Scopinho, A.A., Guimarães, F.S., Corrêa, F.M. and Resstel, L.B. (2011): Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacol. Biochem. Behav., 98, 268-272.
12. Shen, L., Tso, P., Woods, S.C., Clegg, D.J., Barber, K.L., Carey, K. and Liu, M. (2008): Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes, 57, 2092-2098.
13. Suzuki, K., Ito, Y., Wakai, K., Kawado, M., Hashimoto, S., Toyoshima, H., Kojima, M., Tokudome, S., Hayakawa, N., Watanabe, Y., Tamakoshi, K., Suzuki, S., Ozasa, K. and Tamakoshi, A.; Japan Collaborative Cohort Study Group (2004): Serum oxidized lowdensity lipoprotein levels and risk of colorectal cancer: a casecontrol study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol. Biomarkers Prev., 13, 1781-1787.
14. Takeda, S., Usami, N., Yamamoto, I. and Watanabe, K. (2009): Cannabidiol-2′,6′-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor. Drug Metab. Dispos., 37, 1733-1737.
15. 9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors. J. Pharm. Sci., 100, 1206-1211.
16. Takeda, S., Hirayama, A., Urata, S., Mano, N., Fukagawa, K., Imamura, M., Irii, A., Kitajima, S., Masuyama, T., Nomiyama, M., Tatei, S., Tomita, S., Kudo, T., Noguchi, M., Yamaguchi, Y., Okamoto, Y., Amamoto, T., Fukunishi, Y., Watanabe, K., Omiecinski, C.J. and Aramaki, H. (2011b): Cannabidiol-2′,6′- dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro. Biol. Pharm. Bull., 34, 1252-1256.
17. Takeda, S. (2013): Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis. Yakugaku Zasshi, 133, 1093-1101.
18. Vasankari, T., Fogelholm, M., Kukkonen-Harjula, K., Nenonen, A., Kujala, U., Oja, P., Vuori, I., Pasanen, P., Neuvonen, K. and Ahotupa, M. (2001): Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int. J. Obes. Relat. Metab. Disord., 25, 205-211.
19. 1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology, 145, 3224-3231.
20. Wiley, J.L., Burston, J.J., Leggett, D.C., Alekseeva, O.O., Razdan, R.K., Mahadevan, A. and Martin, B.R. (2005): CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br. J. Pharmacol., 145, 293-300.
21. 1A receptors. Br. J. Pharmacol., 159, 122-128.